<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00452049</url>
  </required_header>
  <id_info>
    <org_study_id>ML3052</org_study_id>
    <nct_id>NCT00452049</nct_id>
  </id_info>
  <brief_title>The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood Pressure</brief_title>
  <official_title>Observational Study to Evaluate the Effect of Parathyroidectomy on Renal Function, Endothelial Function and Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Secondary hyperparathyroidism (HPT) is a known complication of chronic renal failure.
      Elevated concentrations of parathyroid hormone (PTH) play a role not only in the pathogenesis
      of renal bone disease, but also in the development of cardiovascular risk factors such as
      disturbed lipid metabolism, glucose intolerance, and hypertension. HPT is also known to play
      an important role in the development of structural abnormalities of both large arteries and
      the heart (left ventricular hypertrophy, interstitial fibrosis). In the last couple of years
      there has been increasing evidence from animal studies that the endothelium is a target organ
      of PTH.

      Hypothesis: PTH has clinically relevant effects on renal hemodynamics, renal function and
      endothelial function.

      Aims:

        1. To evaluate the effect of parathyroidectomy (PTX) on renal hemodynamics in stable renal
           transplant recipients

        2. To evaluate the effect of PTX on endothelial function in stable renal transplant
           recipients/chronic kidney disease (CKD) stage 5 patients

        3. To evaluate the effect of PTX on blood pressure in stable renal transplant
           recipients/CKD stage 5 patients
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2005</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hyperparathyroidism</condition>
  <condition>Hypertension</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>parathyroidectomy</intervention_name>
    <description>parathyroidectomy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Renal transplant recipients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Stable renal transplant recipients/CKD stage 5D patients.

          2. Age between 18 years and 85 years.

          3. Signed informed consent.

          4. PTX scheduled because of severe hyperparathyroidism (day 0)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pieter Evenepoel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pieter Evenepoel, MD, PhD</last_name>
    <phone>003216344580</phone>
    <email>pieter.evenepoel@uz.kuleuven.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hopsital Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter Evenepoel, MD, PhD</last_name>
      <phone>003216344580</phone>
      <email>pieter.evenepoel@uz.kuleuven.ac.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2007</study_first_submitted>
  <study_first_submitted_qc>March 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2007</study_first_posted>
  <last_update_submitted>May 28, 2012</last_update_submitted>
  <last_update_submitted_qc>May 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Evenepoel Pieter</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>parathyroidectomy</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>renal function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperparathyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

